This trispecific TCE was designed to address the tumor heterogeneity of glioblastoma and demonstrated efficient tumor growth control in a GBM model with heterogenous expression of IL13Rα2 and EGFRvIII, resembling the complex tumor environment in human GBM (34). The gene discussed is IL13RA2; the disease is neoplasm.